Concourse Financial Group Securities’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-134
Closed -$2.12K 1419
2024
Q4
$2.12K Buy
134
+23
+21% +$375 ﹤0.01% 2007
2024
Q3
$2.13K Sell
111
-57
-34% -$1.18K ﹤0.01% 1984
2024
Q2
$3.48K Sell
168
-3
-2% -$60 ﹤0.01% 1934
2024
Q1
$3.21K Sell
171
-440
-72% -$7.55K ﹤0.01% 1974
2023
Q4
$8.82K Buy
611
+19
+3% +$258 ﹤0.01% 1715
2023
Q3
$10.3K Sell
592
-53
-8% -$1.1K ﹤0.01% 1635
2023
Q2
$13.4K Sell
645
-21
-3% -$456 ﹤0.01% 1573
2023
Q1
$15.7K Sell
666
-1
-0.1% -$27 ﹤0.01% 1539
2022
Q4
$18.6K Sell
667
-228
-25% -$5.83K ﹤0.01% 1494
2022
Q3
$21K Buy
895
+9
+1% +$272 ﹤0.01% 1296
2022
Q2
$30K Sell
886
-61
-6% -$2.14K ﹤0.01% 1292
2022
Q1
$33K Sell
947
-8
-0.8% -$274 ﹤0.01% 1300
2021
Q4
$29K Sell
955
-958
-50% -$31.2K ﹤0.01% 1510
2021
Q3
$63K Sell
1,913
-708
-27% -$22.7K ﹤0.01% 1213
2021
Q2
$79K Buy
+2,621
New +$86.3K ﹤0.01% 1091

Other funds holding OGN

Concourse Financial Group Securities's OGN Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 134 shares — an estimated $2.12K sold.

Concourse Financial Group Securities first reported a position in OGN in Q2 2021 and held it in 15 quarters. The position peaked at $79K in Q2 2021. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 134 Organon & Co shares in Q1 2025, an estimated $2.12K.
  • Concourse Financial Group Securities first reported a position in Organon & Co in Q2 2021 and held it in 15 quarters.
  • Concourse Financial Group Securities's Organon & Co position peaked at $79K in Q2 2021.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.